DIABETES WITH DIABETIC AUTONOMIC NEUROPATHY (DIAGNOSIS)

Clinical trials for DIABETES WITH DIABETIC AUTONOMIC NEUROPATHY (DIAGNOSIS) explained in plain language.

Never miss a new study

Get alerted when new DIABETES WITH DIABETIC AUTONOMIC NEUROPATHY (DIAGNOSIS) trials appear

Sign up with your email to follow new studies for DIABETES WITH DIABETIC AUTONOMIC NEUROPATHY (DIAGNOSIS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Diabetes drug may shield heart nerves from damage

Disease control Recruiting now

This study looks at whether a class of diabetes drugs called GLP-1 receptor agonists (like semaglutide) can improve nerve damage in the heart caused by type 2 diabetes. About 60 adults with type 2 diabetes will receive either standard care or standard care plus a weekly injection…

Matched conditions: DIABETES WITH DIABETIC AUTONOMIC NEUROPATHY (DIAGNOSIS)

Phase: PHASE4 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control

Last updated May 26, 2026 05:50 UTC

DIABETES WITH DIABETIC AUTONOMIC NEUROPATHY (DIAGNOSIS)

Get alerted when new DIABETES WITH DIABETIC AUTONOMIC NEUROPATHY (DIAGNOSIS) trials appear

Diabetes drug may shield heart nerves from damage